全文获取类型
收费全文 | 2842篇 |
免费 | 329篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 135篇 |
妇产科学 | 75篇 |
基础医学 | 278篇 |
口腔科学 | 4篇 |
临床医学 | 742篇 |
内科学 | 402篇 |
皮肤病学 | 14篇 |
神经病学 | 103篇 |
特种医学 | 29篇 |
外科学 | 473篇 |
综合类 | 276篇 |
现状与发展 | 1篇 |
预防医学 | 151篇 |
眼科学 | 6篇 |
药学 | 377篇 |
3篇 | |
中国医学 | 52篇 |
肿瘤学 | 78篇 |
出版年
2023年 | 24篇 |
2022年 | 39篇 |
2021年 | 67篇 |
2020年 | 63篇 |
2019年 | 66篇 |
2018年 | 65篇 |
2017年 | 66篇 |
2016年 | 64篇 |
2015年 | 76篇 |
2014年 | 115篇 |
2013年 | 157篇 |
2012年 | 115篇 |
2011年 | 123篇 |
2010年 | 100篇 |
2009年 | 182篇 |
2008年 | 193篇 |
2007年 | 108篇 |
2006年 | 88篇 |
2005年 | 70篇 |
2004年 | 72篇 |
2003年 | 85篇 |
2002年 | 62篇 |
2001年 | 263篇 |
2000年 | 233篇 |
1999年 | 170篇 |
1998年 | 26篇 |
1997年 | 27篇 |
1996年 | 19篇 |
1995年 | 24篇 |
1994年 | 14篇 |
1993年 | 19篇 |
1992年 | 23篇 |
1991年 | 19篇 |
1990年 | 19篇 |
1989年 | 16篇 |
1988年 | 15篇 |
1987年 | 12篇 |
1986年 | 19篇 |
1985年 | 53篇 |
1984年 | 53篇 |
1983年 | 39篇 |
1982年 | 22篇 |
1981年 | 23篇 |
1980年 | 15篇 |
1979年 | 24篇 |
1978年 | 10篇 |
1977年 | 13篇 |
1976年 | 6篇 |
1975年 | 7篇 |
1973年 | 5篇 |
排序方式: 共有3201条查询结果,搜索用时 3 毫秒
1.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(12):2883-2889
Background and aimsCoronary artery disease (CAD) is the principal cause of death in individuals with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to use genetic epidemiology to study the association between de novo lipogenesis (DNL), one of the major pathways leading to NAFLD, and CAD risk.Methods and resultsDNL susceptibility genes were used as instruments and selected using three approaches: 1) genes that are associated with both high serum triglycerides and low sex hormone-binding globulin, both downstream consequences of DNL (unbiased approach), 2) genes that have a known role in DNL (biased approach), and 3) genes that have been associated with serum fatty acids, used as a proxy of DNL. Gene-CAD effect estimates were retrieved from the meta-analysis of CARDIoGRAM and the UK Biobank (~76014 cases and ~264785 controls). Effect estimates were clustered using a fixed-effects meta-analysis. Twenty-two DNL susceptibility genes were identified by the unbiased approach, nine genes by the biased approach and seven genes were associated with plasma fatty acids. Clustering of genes selected in the unbiased and biased approach showed a statistically significant association with CAD (OR:1.016, 95%CI:1.012; 1.020 and OR:1.013, 95%CI:1.007; 1.020, respectively), while clustering of fatty acid genes did not (OR:1.004, 95%CI:0.996–1.011). Subsequent exclusion of potential influential outliers did reveal a statistically significant association (OR:1.009, 95%CI:1.000; 1.018).ConclusionsDNL susceptibility genes are associated with an increased risk of CAD. These findings suggest that DNL may be involved in the pathogenesis of CAD and favor further development of strategies that target NAFLD through DNL. 相似文献
2.
对血清蛋白白球比值参考范围的修改及其临床应用 总被引:1,自引:0,他引:1
李学军 《实用医药杂志(山东)》2006,23(1):34-35
目的探讨血清蛋白白球比值(A/G)的参考范围和A/G在计算过程中产生的误差对临床应用的影响。方法①选取健康查体人员统计其A/G参考范围;②从理论上分析A/G计算误差的存在。结果①以统计结果的2s置信区间作为A/G的参考范围是1.1~2.2;②A/G计算值的误差会远大于相应总蛋白和白蛋白的测定误差。结论A/G较合适的参考范围为1.1~2.2,并且在临床应用中仍可根据实际情况降低其范围的下限。 相似文献
3.
Benedita Sampaio-Maia Mónica Moreira-Rodrigues Paula Serr?o Manuel Pestana 《Nephrology, dialysis, transplantation》2006,21(2):314-323
BACKGROUND: A primary tubular sodium handling abnormality has been implicated in the edema formation of nephrotic syndrome. Dopamine synthesized by renal proximal tubules behaves as an endogenous natriuretic hormone by activating D(1)-like receptors as a paracrine/autocrine substance. METHODS: We examined the time courses of the urinary excretion of sodium, protein and dopamine in puromycin aminonucleoside (PAN)-treated and control rats. The rats were sacrificed during greatest sodium retention (day 7) as well as during negative sodium balance (day 14) for the evaluation of renal aromatic l-amino acid decarboxylase (AADC) activity, the enzyme responsible for the synthesis of renal dopamine. Also, the influence of volume expansion (VE) and the effects of the D(1)-like agonist fenoldopam (10 microg/kg bw/min) on natriuresis and on proximal tubular Na(+),K(+)-ATPase activity were examined on day 7. RESULTS: The daily urinary excretion of dopamine was decreased in PAN-treated rats, from day 5 and beyond. This was accompanied by a marked decrease in the renal AADC activity, on days 7 and 14. During VE, the fenoldopam-induced decrease in proximal tubular Na(+),K(+)-ATPase activity was more pronounced in PAN-treated rats than in controls. However, the urinary sodium excretion during fenoldopam infusion was markedly increased in control rats but was not altered in PAN-treated animals. CONCLUSION: PAN nephrosis is associated with a blunted renal dopaminergic system activity which may contribute to enhance the proximal tubular Na(+),K(+)-ATPase activity. However, the lack of renal dopamine appears not to be related with the overall renal sodium retention in a state of proteinuria. 相似文献
4.
笔者复习相关文献,对腹茧症的病因、病理、临床特点、诊断及治疗等方面的研究现状作一综述,旨在加深临床医生对该病的认识。 相似文献
5.
Abstract The outcome of OLT for HBV-related liver disease is dependent on the prevention of allograft re-infection. Over the past decade, major advances have been made in the management of HBV transplant candidates. The advent of long-term hepatitis B immune globulin (HBIG) administration as a prophylaxis against HBV recurrence, and the introduction of new antiviral agents against HBV infection, such as lamivudine (LAM), were a major breakthrough in the management of these patients. Results of OLT for HBV infection are similar to those achieved with other indications. Pre-OLT antiviral treatment such as LAM can suppress HBV replication before OLT and thus decrease the risk of re-infection of the graft. Combination prophylaxis with LAM and HBIG after transplantation highly effectively reduces the rate of HBV re-infection, even in HBV replicative cirrhotic, patients. The optimal HBIG protocol in the LAM era is yet to be defined: dosing of HBIG, routes of administration, and possibility of stopping HBIG. Several antiviral drugs have been developed for the management of HBV infection on the graft, so outcome is currently good. 相似文献
6.
7.
丙种球蛋白治疗危重早产儿临床分析 总被引:1,自引:0,他引:1
目的 为评估IVIG治疗危重早产儿的临床疗效。方法 将危重早产儿116例采取随机分为治疗组和对照组,对照组给常规综合治疗,治疗组在常规综合治疗措施上,加用IVIG静脉滴注,比较治疗组与对照组患儿病情平稳率及死亡率。结果 IVIG治疗危重早产儿病情平稳率第5天达75.8%第10天达93.3%,而对照组分别为50%和70.4%;病死率治疗组为6.4%,对照组为11.1%,均优于常规对照组。结论 危重早产儿用IVIG治疗疗效较满意,值得推广。 相似文献
8.
用人血进行体外实验研究证实,五叶参水煮制备液能明显抑制APD、复合诱聚剂诱导的血小板1min、5min、最大聚集率,并促进解聚发生(P均<0.05);该药还对体外血栓形成具有显著的抑制作用(P<0.05);五叶参水煮液与PPP混合后,尚能抑制多种凝血因子活性,使KPTT、PT、TT、AT、RVV-RT、RVV-CT等凝血试验时间延长(P均<0.05);此外,五叶参有加速红细胞电泳速度的作用。上述结果表明,五叶参是一种具有抑制血小板功能、凝血功能及红细胞聚集性等多个环节的抗血栓形成药物,值得进一步研究探讨。 相似文献
9.
E. J. Ramos H. S. Pollinger M. D. Stegall J. M. Gloor A. Dogan J. P. Grande 《American journal of transplantation》2007,7(2):402-407
Rituximab, intravenous immunoglobulin (IVIG) and rabbit antithymocyte globulin (rATG) all have been suggested to have an effect on antibody producing cells, however, supporting data are lacking. To assess the impact of these agents on splenic B‐cell populations in vivo, we retrospectively examined 25 spleens removed from patients treated with these agents as part of desensitization protocols in either ABO incompatible or positive crossmatch living donor kidney transplantation. These were compared to control (CTL) spleens removed for trauma. CTLs and spleens removed at transplant after multiple pretransplant plasmaphereses (PP) plus low‐dose IVIG showed similar large numbers of naïve B cells (CD20+ and CD79+), plasma cells (CD138+) and memory B cells (CD27+ cells). Adding rituximab to this PP/IVIG regimen reduced the number naïve B cells, but had no effect on memory or plasma cells. Combination treatment (PP/IVIG, rituximab and rATG) showed a trend toward the reduction of CD27+ cells, but again plasma cells were unchanged. We conclude that none of these protocols reduces splenic plasma cells in vivo. PP/low‐dose IVIG does not alter splenic B cells, but the addition of rituximab decreases mature B cells. Memory B cells may be affected by combination therapy including rATG and requires further study. 相似文献
10.
目的探讨短程5-FU/CF方案新辅助化疗对结直肠癌细胞凋亡、增殖和p53表达以及术后并发症和预后的影响。方法分别采用脱氧核糖核苷酸末端转移酶介导的缺口末端标记法(TUNEL)和免疫组化SP法检测68例患者结直肠癌组织的细胞凋亡指数(AI)和ki-67增殖指数(PI)及凋亡相关基因p53的表达,并比较新辅助化疗组和对照组患者术后并发症的发生情况和预后情况。结果新辅助化疗组肿瘤细胞的AI均数为3.56%,明高于对照组的2.29%(P〈0.01),PI均数为22.60%明显低于对照组的33.60%(P〈0.01),p53阳性表达率为28.9%(11/38)明显低于对照组的56.7%(17/30)(P〈0.05)。两组中大肠癌细胞的AI与PI均呈负相关(r=-0.790,r=-0.663)(P〈0.01)。两组术后并发症的发生差异无显著性(P〈0.05)。两组的复发转移率和复发转移平均时间差异有显著性(P〈0.05)。结论短程5-FU/CF方案新辅助化疗可以显著诱导结直肠癌细胞凋亡,并抑制其增殖;降低结直肠癌组织p53的阳性表达率,而不增加术后并发症的发生,能延缓和减少结直肠癌术后的复发转移。 相似文献